Redirection of cytokine production by lymphocytes from women with pre-term delivery by dydrogesterone

American Journal of Reproductive Immunology

Volumn 58, Issue 1, 2007, Pages 31-38

  Raghupathy, Raj ^a   Al Mutawa, Esraa ^a   Makhseed, Ma'asoumah ^a   Al azemi, Majedah ^a   Azizieh, Fawaz ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Cytokines; Dydrogesterone; Pre term delivery; Progesterone

Indexed keywords

CYTOKINE; DYDROGESTERONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL STIMULATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREMATURE LABOR; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

CELLS, CULTURED; CYTOKINES; DYDROGESTERONE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; PHYTOHEMAGGLUTININS; PREGNANCY; PREMATURE BIRTH; TUMOR NECROSIS FACTORS;

EID: 34250636715     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00488.x     Document Type: Article

References (49)

1. Iams JD, Creasy RK: Preterm labour and delivery. In Maternal-Fetal Medicine, RK Creasy, JD Iams, R Resnik (eds). Philadelphia, Saunders, 2004, pp 623-661.
2. Hamilton BE, Martin JA, Ventura SJ, Sutton PD, Menacker F: Births: preliminary data for 2004. National Vital Statistics Reports (U.S. Department of Health and Human Services) 2005; 54: 1-17.
3. Cunningham FG, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD, Bloom SL: Williams Obstetrics. New York, McGraw-Hill Education, 2005.
4. Lang JM, Lieberman E, Cohen A: A comparison of risk factors for preterm labor and term small-for-gestational age birth. Epidemiology 1996; 7: 329-376.
5. Lamont RF, Elder MG: The prevention of preterm birth. In The Yearbook of the RCOG, JWW Studd (ed). London, RCOG Press, 1995, pp 369-382.
6. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14: 353-356.
7. Hill JA, Anderson DJ, Polgar K: T helper 1-type cellular immunity to trophoblast in women with recurrent spontaneous abortions. J Am Med Assoc 1995; 273: 1933-1958.
8. RaghuSathy R: Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol 2001; 13: 219-227.
9. Mosmann TR, Sad S: The expanding universe of T-cell subsets. Immunol Today 1996; 17: 138-146.
10. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA: The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis and chorioamnion infection. Obstet Gynecol 1983; 14: 353-356.
11. Keelan JA, Blumenstein M, Helliwell RJA, Sato TA, Marvin KW, Mitchell MD: Cytokines, prostaglandins and parAurition: a review. Placenta 2003; 24 (Suppl A 17): S33-S46.
12. Chuilennain FN, Brennecke S: Prediction of preterm labor in multiple pregnancies. Baillieres Clin Obstet Gynaecol 1998; 12: 53-66.
13. Steinborn A, Niederhut A, Solbach C, Hildenbrand R, Sohn C, Kaufmann M: Cytokine release from placental endothelial cells, a process associated with preterm labor in the absence of intrauterine infection. Cytokine 1999; 11: 166-173.
14. Keelan JA, Marvin KW, Sato TA, Coleman M, McCowan LM, Mitchell MD: Cytokine abundance in placental tissues: Evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am J Obstet Gynecol 1999; 181: 1530-1536.
15. Lockwood CJ, Ghidini A, Wein R, Lapinski R, Casal D, Berkowitz RL: Increased interleukin-6 concentrations in cervical secretions are associated with preterm delivery. Am J Obstet Gynecol 1994; 171: 1097-1102.
16. Inglis SR, Jeremias J, Kuno K, Lescale K, Peeper Q, Chervenak FA: Detection of tumor necrosis factor- α, interleukin-6 and fetal fibronectin in the lower genital tract during pregnancy: Relation to outcome. Am J Obstet Gynecol 1994; 171: 5-10.
17. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM: A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998; 179: 186-193.
18. Mitchell MD, Trautman MS, Dudley DJ: Immunoendocrinology of preterm labor and delivery. Baillieres Clin Obstet Gynaecol 1993; 7: 553-575.
19. Dudley DJ:APre-term labor: an intra-uterine inflammatory response syndrome? J Reprod Immunol 1997; 36: 93-109.
20. Steinborn A, Gunes H, Roddiger S, Halberstadt E: Elevated placental cytokine release, a process associated with preterm labor in the absence of intrauterine infection. Obstet Gynecol 1996; 88: 534-539.
21. Arntzen KJ, Kjolesdal AM, Halgunset J, Vatten L, Austgulen R: TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med 1998; 26: 17-26.
22. Makhseed M, Raghupathy R, El-Shazly S, Azizieh F, Al-Harmi JA: Pro-inflammatory maternal cytokine profile in preterm delivery. Am J Reprod Immunol 2003; 49: 1-12.
23. El-Shazly S, Makhseed M, Azizieh F, Raghupathy R: Increased expression of pro-inflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes. Am J Reprod Immunol 2004; 52: 45-52.
24. Dudley DJ: Immunoendocrinology oT preterm labor: the link between corticotrophin-releasing hormone and inflammation. Am J Obstet Gynecol 1999; 180: S251-S256.
25. Stites DP, Bugbee S, Siiteri PK: Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation -relevance to immunosuppression in pregnancy. J Reprod Immunol 1983; 5: 215-228.
26. Piccinni MP, Giudizi MG, Biagiotti R, Beloni L. Giannarini L. Sampognaro S, Parronchi P, Manetti R, Annunziato F, Livi C: Progesterone favors the development of human t helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established T cell clones. J Immunol 1995; 155: 128-133.
27. Choi BC, Polgar K, Xiao L, Hill JA: Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 2000; 15 (Suppl. 1): 46-59.
28. Bowen JM, Chamley L, Keelan JA, Mitchell MD: Cytokines of the placenta and extra-placental membranes: Roles and regulation during human pregnancy and parturition. Placenta 2002; 23: 257-273.
29. Makhseed M, Raghupathy R, Azizieh F, Al-Azemi MMK, Hassan NA, Bandar A: Mitogen-induced cytokine responses of maternal lymphocytes suggest a differential Th-type bias in normal pregnancy and pregnancy failure. Am J Reprod Immunol 1999; 42: 273-281.
30. Szekeres-Bartho J. Immunosuppression by Progesterone in Pregnancy. Boca-Raton, L CRC Press, 1992.
31. Doggrell SA: Recurrent hope for the treatment of preterm delivery. Expert Opin Pharmacother 2003; 4: 2362-2366.
32. Meis PJ, Klebanoff M, Thiom E, Dombrowski MP, Sibai B et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379-2385.
33. Meis PJ, Klebanoff M, Dombrowski MP, Sibai BM, Leindecker S, Moawad AM, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM Jr, Peaceman AM, Gabbe S: Does progesterone treatment influence risk factors for recurrent preterm delivery? Obstet Gynecol 2005; 106: 557-561.
34. Sanchez-Ramos L, Kaunitz AM, Delke I: Progestational agents to prevent preterm birth: A meta-analysis of randomized controlled trials. Obstet Gynecol 2005; 105: 273-279.
35. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M: Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blid study. Am J Obstet Gynecol 2003; 188: 419-424.
36. Bowes WA: Editorial comment. Obstet Gynecol Surv 2003; 58: 704-706.
37. Meis PJ, Connors N: Progesterone treatment to prevent preterm birth. Clin Obstet Gynecol 2004; 47: 784-795.
38. Hollier LM: PreventiWg preterm birth: what works, what doesn't. Obstet Gynecol Surv 2005; 60: 124-131.
39. Sato TA, Keelan JA, Mitchell MD: Critical paracrine interactions between TNF-alpha and IL-10 regulate lipopolysaccharide-stimulated human choriodecidual cytokine and prostaglandin E2 production. J Immunol 2003; 170: 158-166.
40. Thornton S, Gillespie JI: Biochemistry of uterine contractions. Contemp Rev Obstet Gynaecol 1992; 4: 121-126.
41. Egarter CA, Hussein P: Biochemistry of myometria contractility. Clin Obstet Gynecol 1992; 6: 755-769.
42. Raghupathy R, Al Mutawa E, Makhseed M, Azizieh F, Szekeres-Bartho J: Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. Br J Obstet Gynaecol 2005; 112: 1096-1101.
43. Szekeres-Bartho J, Chaouat G: Lymphocyte-derived, progesterone-induced blocking factor corrects resorption in a murine abortion system. Am J Reprod Immunol 1990; 23: 26-28.
44. Szekeres-Bartho J, Par G, Dombay G, Smart CY, Volgyi Z: The anti-abortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity. Cell Immunol 1997; 177: 194-199.
45. Polgar B, Nagy E, Miko E, Varga P, Szekeres-Bartho J: Urinary progesterone-induced blocking factor. Biol Reprod 2004; 71: 1699-1705.
46. Stanczyk FZ: Pharmacokinetics of progesterone administered by the oral and parenteral routes. J Reprod Med 1999; 44: 141-147.
47. Simon JA, Robinson DE, Andrews MC, Hildebrand JR III, Rocci ML, Blake RE. Hodgen GD: The absorption of oral micrTnised progesterone: the effect of food, dose proportionality and comparison with intramuscular progesterone. Fertil Steril 1993; 60: 26-33.
48. Maxson WS, Hargrove JT: Bioavailability of oral micronized progesterone. Fertil Steril 1985; 44: 622-626.
49. McAuley JW, Kroboth FJ, Kroboth PD: Oral administration of micronized progesterone -a review and more experience. Pharmacotherapy 1996; 16: 453-457.